These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 21129594)

  • 1. [Calamities in movement disorders].
    Mínguez-Castellanos A
    Neurologia; 2010 Oct; 25 Suppl 1():24-9. PubMed ID: 21129594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parallels between neuroleptic effects and lethargic encephalitis: the production of dyskinesias and cognitive disorders.
    Breggin PR
    Brain Cogn; 1993 Sep; 23(1):8-27. PubMed ID: 8105824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroleptic malignant syndrome.
    Bristow MF; Kohen D
    Br J Hosp Med; 1996 Apr 17-30; 55(8):517-20. PubMed ID: 8732227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prosthetic dentistry in the treatment of movement disorders: dyskinesias and other neurological abnormalities.
    Sutcher H
    Med Hypotheses; 2001 Mar; 56(3):318-20. PubMed ID: 11359353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Iatrogenic movement disorders].
    Soeur M
    Rev Med Brux; 2008 Sep; 29(4):232-7. PubMed ID: 18949970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and neurobiologic implications of antipsychotic-induced movement disorders.
    Rubin EH; Zorumski CF
    Compr Ther; 1986 Oct; 12(10):61-7. PubMed ID: 2877769
    [No Abstract]   [Full Text] [Related]  

  • 7. Akinetic crisis, acute akinesia, neuroleptic malignant-like syndrome, Parkinsonism-hyperpyrexia syndrome, and malignant syndrome are the same entity and are often independent of treatment withdrawal.
    Thomas A; Onofrj M
    Mov Disord; 2005 Dec; 20(12):1671; author reply 1671-2. PubMed ID: 16149099
    [No Abstract]   [Full Text] [Related]  

  • 8. Pathogenesis, prevention, and treatment of neuroleptic-induced movement disorders.
    Ebadi M; Srinivasan SK
    Pharmacol Rev; 1995 Dec; 47(4):575-604. PubMed ID: 8746555
    [No Abstract]   [Full Text] [Related]  

  • 9. Neuroleptic malignant syndrome and acute myocardial infarction: case report and review.
    Freedman MD
    Md Med J; 1997 Aug; 46(7):357-9. PubMed ID: 9260471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroleptic malignant syndrome in elderly patients.
    Caroff SN; Campbell EC; Sullivan KA
    Expert Rev Neurother; 2007 Apr; 7(4):423-31. PubMed ID: 17425496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Four oral motor disorders: bruxism, dystonia, dyskinesia and drug-induced dystonic extrapyramidal reactions.
    Clark GT; Ram S
    Dent Clin North Am; 2007 Jan; 51(1):225-43, viii-ix. PubMed ID: 17185068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Movement disorders emergencies. Part 1: Hypokinetic disorders.
    Robottom BJ; Weiner WJ; Factor SA
    Arch Neurol; 2011 May; 68(5):567-72. PubMed ID: 21555633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The evaluation and management of patients with neuroleptic malignant syndrome.
    Bhanushali MJ; Tuite PJ
    Neurol Clin; 2004 May; 22(2):389-411. PubMed ID: 15062519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroleptic-induced movement disorders: an overview.
    Sachdev PS
    Psychiatr Clin North Am; 2005 Mar; 28(1):255-74, x. PubMed ID: 15733622
    [No Abstract]   [Full Text] [Related]  

  • 15. Neuroleptic malignant syndrome: a patient report.
    Tansey L; Malone J
    Ir Med J; 1987 May; 80(5):156. PubMed ID: 2885294
    [No Abstract]   [Full Text] [Related]  

  • 16. Neurologic complications of drugs. Tardive dyskinesias, neuroleptic malignant syndrome, and cocaine-related syndromes.
    Rodnitzky RL; Keyser DL
    Psychiatr Clin North Am; 1992 Jun; 15(2):491-510. PubMed ID: 1351285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Symptomatology of movement disorders in children].
    Czochanska J
    Med Wieku Rozwoj; 2001; 5(2):173-8. PubMed ID: 11679682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The neuroleptic malignant syndrome.
    Dickey W
    Prog Neurobiol; 1991; 36(5):425-36. PubMed ID: 1679565
    [No Abstract]   [Full Text] [Related]  

  • 19. Movement disorder emergencies.
    Kipps CM; Fung VS; Grattan-Smith P; de Moore GM; Morris JG
    Mov Disord; 2005 Mar; 20(3):322-34. PubMed ID: 15584031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-induced movement disorders.
    Gershanik OS
    Curr Opin Neurol Neurosurg; 1993 Jun; 6(3):369-76. PubMed ID: 8099509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.